It sounds too good to be true, but a novel approach that might allow you to eat as much as you want without gaining weight could be a reality in the near future.
When a single gene known as RCAN1 was removed in mice and they were fed, they failed to gain weight, even after gorging on high-fat foods for prolonged periods.
The international team, led by Associate Professor Beverly Rothermel at the University of Texas Southwestern Medical Center and Professor Damien Keating at Flinders University, are hopeful a similar approach that inhibits this gene will also be effective with humans to combat obesity and serious diseases like diabetes.
The study used a large genetic screen in rodents to identify novel genetic candidates that may cause obesity, potentially paving the way for new drug therapies.
“We know a lot of people struggle to lose weight or even control their weight for a number of different reasons,” says Professor Keating, from the Molecular and Cellular Physiology Laboratory at the College of Medicine and Public Health at Flinders.
“The findings in this study could mean developing a pill which would target the function of RCAN1 and may result in weight loss,” he says.
Obesity is a major global health epidemic, resulting in increased risk of serious diseases like type 2 diabetes, and heart disease, but avenues for effective therapeutic treatments are lacking.
There are two types of fat in the human body – brown fat burns energy, while white fat stores energy.
Professor Keating says blocking RCAN1 helps to transform unhealthy white fat into healthy brown fat, presenting a potential treatment method in the fight against obesity.
“We have already developed a series of drugs that target the protein that this gene makes, and we are now in the process of testing them to see if they inhibit RCAN1 and whether they might represent potential new anti-obesity drugs,” he says.
“In light of our results, the drugs we are developing to target RCAN1 would burn more calories while people are resting.
“It means the body would store less fat without the need for a person to reduce food consumption or exercise more.”
Two-thirds of Australian adults and a quarter of children are either overweight or obese, and the statistics are just as concerning in Britain and the US.
“Co-investigators in the research, Dr David Rotter and Heshan Peiris, looked at a variety of different diets with various timespans from eight weeks up to six months, and in every case we saw health improvements in the absence of the RCAN1 gene,” says Professor Keating, an NHMRC Principal Research Fellow at the Centre for Neuroscience at Flinders University.
The researchers say these findings open up a potentially simple treatment but further studies are required to determine if they translate the same results to humans.
“Our research is focused on understanding how cells send signals to each other and how this impacts health and the spread of disease”.
“We really want to pursue this, it’s exciting and we have research funding from the Australian government through the National Health and Medical Research Council (NHMRC) to continue to explore viable options.
“These results show we can potentially make a real difference in the fight again obesity.”
Learn more: Gene discovery holds promise against obesity
The Latest on: Obesity
[google_news title=”” keyword=”obesity” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Obesity
- China Focus: Health experts urge scientific interventions to combat obesityon May 11, 2024 at 2:36 pm
According to a 2020 report by China's National Health Commission (NHC), 34.3 percent of the country's citizens aged 18 and above were overweight and 16.4 percent were obese. Research predicts that the ...
- Supported Exercise Intervention Helps Black Women With Obesity Shed Weighton May 11, 2024 at 2:14 pm
NEW ORLEANS -- A "culturally sensitive" exercise intervention led to weight loss and other benefits in African-American women with obesity at risk for diabetes, researchers reported.
- Poor Muscle Health in Obesity Raises Early Death Riskon May 11, 2024 at 12:37 pm
Despite having more muscle mass, individuals with obesity often have weaker muscles, showing lower quality and reduced mobility/function.
- Obesity linked to 'several cancer types'on May 11, 2024 at 11:14 am
Becoming fat could be a prominent factor which is likely to cause four out of 10 cancers, as per the findings of a major study.Obesity can now be linked to 32 types of tumour, which are 19 more ...
- Nearly half of all cancer cases are linked to obesityon May 10, 2024 at 1:00 pm
Nearly half of all cancer cases are linked to obesity, new research has found. The study of more than four million adults, who were tracked for decades, found excess weight could be fuelling more than ...
- The public wants Medicare to cover obesity drugson May 10, 2024 at 6:07 am
Medicare is currently barred from covering drugs for weight losses purposes. But roughly 61% of adults say they think Medicare should cover these medications, including 66% of Democrats and 55% of ...
- India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO sayson May 10, 2024 at 2:52 am
Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company's CEO said on Friday.
- Why does working a night shift raise the risk for diabetes and obesity? Experts weigh inon May 9, 2024 at 2:29 pm
Working a night shift for even a short time could negatively impact your health and scientists are researching why.
- How we can bridge the obesity-care gap for Black Americanson May 9, 2024 at 6:23 am
OPINION: It is time to advocate for legislative changes that will ensure every individual has access to life-saving medical treatments for obesity. The post How we can bridge the obesity-care gap for ...
- Novo Nordisk ties up with Metaphore to develop new obesity drugson May 9, 2024 at 5:55 am
Novo Nordisk signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs.
via Bing News